AXT shares climbed sharply in morning trading, rising 6.3% as investors reacted to a material supply agreement involving its subsidiary, AXT-Tongmei. The three-year Master Development and Supply Agreement with Coherent Corp. covers 6-inch indium phosphide wafer substrates and was disclosed in an SEC Form 8-K filed on July 2, 2026.
Under the terms revealed in the 8-K, the Coherent deal extends through June 2029 and includes a $22.3 million prepayment from Coherent. AXT has stated that the prepayment will finance expansion of manufacturing capacity at its Beijing facility during the 2026-2028 timeframe. The arrangement provides AXT with a committed customer for the covered period and upfront capital specifically allocated to scale production capacity at that site.
This Coherent agreement complements an earlier, separate long-term contract for indium phosphide wafers that AXT-Tongmei secured with Nanjing Casela Technologies, which is valued at approximately $25.4 million. That contract is structured with an 80% minimum take-or-pay commitment and includes cancellation penalties, provisions that the company says bolster revenue visibility tied to the agreement.
Investor sentiment has also been shaped by recent analyst activity and index inclusion. Northland Capital has reiterated an Outperform rating on the stock and set a $125 price target, explicitly characterizing sharp pullbacks as buying opportunities. Separately, AXT’s addition to the Russell 2000 and the broader Russell family of indexes has brought a new layer of institutional demand to the shares.
The stock’s gain stood out against a weakening broader market. On the same trading day the S&P 500 was down 0.5%, the Dow off 0.9% and the Nasdaq slipped 0.3%, marking AXT’s move as company-specific rather than market-driven. Sector peers are also seeing tailwinds from the same demand drivers: companies in the compound semiconductor and optical networking spaces, including Coherent and Lumentum Holdings, are benefiting from an AI data center infrastructure buildout that is increasing demand for indium phosphide substrates.
Market-watchers will be looking to AXT’s upcoming quarterly report for concrete evidence of how these supply agreements are translating into financial results. The company’s next earnings release is scheduled for July 30, 2026, a date analysts expect will deliver more definitive data on revenue recognition, capacity utilization and the conversion of contracted demand into reported sales.
Analyst and market context
Taken together, the combination of contracted revenue streams, an upfront prepayment to fund capacity expansion and visible long-term commitments has reframed AXT — in investors’ view — as a higher-visibility participant in the AI infrastructure supply chain. That repositioning appears to be a primary driver of the stock’s momentum amid a declining broader market.
Investors will still be watching execution and near-term reporting to see if bookings and the prepayment translate into sustained revenue growth and higher capacity utilization at the Beijing facility.